THOMPSON

At Biovest International, a personalized medicine company specializing in Dasiprotimut-T, an autologous therapeutic cancer vaccine to fight non-Hodgkin's lymphoma, Rebecca was a Quality Control Senior Scientist. She developed and validated bioanalytical assays for different stages of the vaccine process. Her direct responsibility involved the completion of eight ELISAs on the Tecan robotics system. This phase III clinical trial drug product was filed with the EMA for marketing approval... Rebecca Thompson, Ph.D., is the Chief Executive Officer at Cell Culture Company (a wholly owned subsidiary of Biovest International) in Minneapolis, MN. Cell Culture Company provides custom protein manufacturing. Services include cell culture, purification, development, quality, and analytical testing for research use only (RUO), in-vitro diagnostics (IVD), and cGMP applications in academia, clinical trials and life sciences. Specifically.